Hartge P - Search Results

1

Population-based study of risk of breast cancer in carriers of BRCA2 mutation.

Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Wacholder S, Tulinius H, Eyfjörd JE. Thorlacius S, et al. Among authors: hartge p. Lancet. 1998 Oct 24;352(9137):1337-9. doi: 10.1016/s0140-6736(98)03300-5. Lancet. 1998. PMID: 9802270

2

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA. Struewing JP, et al. Among authors: hartge p. N Engl J Med. 1997 May 15;336(20):1401-8. doi: 10.1056/NEJM199705153362001. N Engl J Med. 1997. PMID: 9145676 Free article.

3

Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history.

Hartge P, Chatterjee N, Wacholder S, Brody LC, Tucker MA, Struewing JP. Hartge P, et al. Epidemiology. 2002 May;13(3):255-61. doi: 10.1097/00001648-200205000-00004. Epidemiology. 2002. PMID: 11964925

4

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.

Rutter JL, Wacholder S, Chetrit A, Lubin F, Menczer J, Ebbers S, Tucker MA, Struewing JP, Hartge P. Rutter JL, et al. Among authors: hartge p. J Natl Cancer Inst. 2003 Jul 16;95(14):1072-8. doi: 10.1093/jnci/95.14.1072. J Natl Cancer Inst. 2003. PMID: 12865453

5

BRCA1 and sex ratio.

Struewing JP, Hartge P, Wacholder S, Tucker MA, Greene MH. Struewing JP, et al. Among authors: hartge p. Eur J Hum Genet. 2004 Aug;12(8):663-7. doi: 10.1038/sj.ejhg.5201210. Eur J Hum Genet. 2004. PMID: 15114373

6

Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma.

Mai PL, Chatterjee N, Hartge P, Tucker M, Brody L, Struewing JP, Wacholder S. Mai PL, et al. Among authors: hartge p. PLoS One. 2009;4(3):e4812. doi: 10.1371/journal.pone.0004812. Epub 2009 Mar 11. PLoS One. 2009. PMID: 19277124 Free PMC article.

7

The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews.

Woodage T, King SM, Wacholder S, Hartge P, Struewing JP, McAdams M, Laken SJ, Tucker MA, Brody LC. Woodage T, et al. Among authors: hartge p. Nat Genet. 1998 Sep;20(1):62-5. doi: 10.1038/1722. Nat Genet. 1998. PMID: 9731533

8

The kin-cohort study for estimating penetrance.

Wacholder S, Hartge P, Struewing JP, Pee D, McAdams M, Brody L, Tucker M. Wacholder S, et al. Among authors: hartge p. Am J Epidemiol. 1998 Oct 1;148(7):623-30. doi: 10.1093/aje/148.7.623. Am J Epidemiol. 1998. PMID: 9778168

9

Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.

Lee JS, Wacholder S, Struewing JP, McAdams M, Pee D, Brody LC, Tucker MA, Hartge P. Lee JS, et al. Among authors: hartge p. J Natl Cancer Inst. 1999 Feb 3;91(3):259-63. doi: 10.1093/jnci/91.3.259. J Natl Cancer Inst. 1999. PMID: 10037104

10

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.

Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA. Hartge P, et al. Am J Hum Genet. 1999 Apr;64(4):963-70. doi: 10.1086/302320. Am J Hum Genet. 1999. PMID: 10090881 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

382 results

Search Page